{"id":63967,"date":"2026-05-12T09:58:13","date_gmt":"2026-05-12T09:58:13","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/63967\/"},"modified":"2026-05-12T09:58:13","modified_gmt":"2026-05-12T09:58:13","slug":"roche-cleared-to-launch-early-alzheimers-test-in-eu-company","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/63967\/","title":{"rendered":"Roche cleared to launch early Alzheimer&#8217;s test in EU: company"},"content":{"rendered":"<p data-block-key=\"w5cmr\">Swiss pharmaceutical giant Roche said Tuesday that it had received clearance from health safety regulators to sell a new blood test for early detection of Alzheimer&#8217;s disease in the European Union.<\/p>\n<p>                  <img loading=\"lazy\" decoding=\"async\" alt=\"Doctor Taking Blood Sample From Patient's Arm in Hospital for Medical Testing\" height=\"532\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/05\/Doctor_Taking_Blood_Sample_From_Patients_Arm.m.width-800.jpg\" width=\"800\"\/><\/p>\n<p>                      Doctor Taking Blood Sample From Patient&#8217;s Arm in Hospital for Medical Testing\/ iStock<\/p>\n<p data-block-key=\"mik02\">The Elecsys pTau217 blood test developed with the US laboratory Eli Lilly measures irregularities in protein structures that can cause the neurodegenerative disease, the company said in a statement.<\/p>\n<p data-block-key=\"fm1t1\">Easier and less uncomfortable than the existing method of taking a spinal fluid sample, the blood test has received the &#8220;CE&#8221; marking indicating that it meets the EU&#8217;s health safety standards.<\/p>\n<p data-block-key=\"dqjub\">The chief executive of the group&#8217;s subsidiary Roche Diagnostics, Matt Sause, said the launch of the test marked &#8220;a significant step&#8221; in providing a diagnosis &#8220;much earlier&#8221;.<\/p>\n<p data-block-key=\"5odro\">&#8220;By bringing this advanced test into routine care, we are helping physicians to support patients and families with an earlier assessment that is critical for timely intervention,&#8221; he said in the statement.<\/p>\n<p data-block-key=\"cvp1a\">Alzheimer&#8217;s disease is the most common form of dementia, but it currently takes an average of three and a half years for it to be diagnosed, Roche said.<\/p>\n<p data-block-key=\"dq4hp\">ALSO READ<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" alt=\"LISTEN TO more news Jacaranda\" height=\"90\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/04\/Listen_to_more_news_Jac_1.original.png\" width=\"728\"\/><\/p>\n<p>          Jacaranda FM<\/p>\n<p>  MORE ON JACARANDA FM<\/p>\n","protected":false},"excerpt":{"rendered":"Swiss pharmaceutical giant Roche said Tuesday that it had received clearance from health safety regulators to sell a&hellip;\n","protected":false},"author":2,"featured_media":63968,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[10078,34943,34948,14442,34944,34945,14439,6903,34906,216,8273,9062,19410,19589,337,34946,134,2057,34947],"class_list":["post-63967","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-alzheimers","tag-alzheimerx27s-disease","tag-alzheimersdisease","tag-blood-test","tag-ce-marking","tag-dementia-diagnosis","tag-diagnostic-testing","tag-early-detection","tag-elecsys-ptau217","tag-eli-lilly","tag-eu-approval","tag-healthcare-innovation","tag-neurodegenerative-disease","tag-pharmaceutical-company","tag-pharmaceuticals","tag-protein-irregularities","tag-roche","tag-roche-diagnostics","tag-timely-intervention"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116561019135701285","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/63967","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=63967"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/63967\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/63968"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=63967"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=63967"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=63967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}